Impact of number of nodes retrieved on outcome in patients with rectal cancer

J. E. Tepper, M. J. O'Connell, D. Niedzwiecki, D. Hollis, C. Compton, A. B. Benson, B. Cummings, L. Gunderson, J. S. Macdonald, R. J. Mayer

Research output: Contribution to journalArticle

Abstract

Purpose: We postulated that the pathologic evaluation of the lymph nodes of surgical specimens from patients with rectal cancer can have a substantial impact on time to relapse and survival. Patients and Methods: We analyzed data from 1,664 patients with T3, T4, or node-positive rectal cancer treated in a national intergroup trial of adjuvant therapy with chemotherapy and radiation therapy. Associations between the number of lymph nodes found by the pathologist in the surgical specimen and the time to relapse and survival outcomes were investigated. Results: Patients were divided into groups by nodal status and the corresponding quartiles of numbers of nodes examined. The number of nodes examined was significantly associated with time to relapse and survival among patients who were node-negative. For the first through fourth quartiles, the 5-year relapse rates were 0.37, 0.34, 0.26, and 0.19 (P = .003), and the 5-year survival rates were 0.68, 0.73, 0.72, and 0.82 (P = .02). No significant differences were found by quartiles among patients determined to be node-positive. We propose that observed differences are primarily related to the incorrect determination of nodal status in node-negative patients. Approximately 14 nodes need to be studied to define nodal status accurately. Conclusion: These results suggest that the pathologic assessment of lymph nodes in surgical specimens is often inaccurate and that examining greater number of nodes increases the likelihood of proper staging. Some patients who might benefit from adjuvant therapy are misclassified as node-negative due to incomplete sampling of lymph nodes.

Original languageEnglish (US)
Pages (from-to)157-163
Number of pages7
JournalJournal of Clinical Oncology
Volume19
Issue number1
StatePublished - Jan 1 2001
Externally publishedYes

Fingerprint

Rectal Neoplasms
Lymph Nodes
Recurrence
Survival
Radiotherapy
Survival Rate
Drug Therapy
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Tepper, J. E., O'Connell, M. J., Niedzwiecki, D., Hollis, D., Compton, C., Benson, A. B., ... Mayer, R. J. (2001). Impact of number of nodes retrieved on outcome in patients with rectal cancer. Journal of Clinical Oncology, 19(1), 157-163.

Impact of number of nodes retrieved on outcome in patients with rectal cancer. / Tepper, J. E.; O'Connell, M. J.; Niedzwiecki, D.; Hollis, D.; Compton, C.; Benson, A. B.; Cummings, B.; Gunderson, L.; Macdonald, J. S.; Mayer, R. J.

In: Journal of Clinical Oncology, Vol. 19, No. 1, 01.01.2001, p. 157-163.

Research output: Contribution to journalArticle

Tepper, JE, O'Connell, MJ, Niedzwiecki, D, Hollis, D, Compton, C, Benson, AB, Cummings, B, Gunderson, L, Macdonald, JS & Mayer, RJ 2001, 'Impact of number of nodes retrieved on outcome in patients with rectal cancer', Journal of Clinical Oncology, vol. 19, no. 1, pp. 157-163.
Tepper JE, O'Connell MJ, Niedzwiecki D, Hollis D, Compton C, Benson AB et al. Impact of number of nodes retrieved on outcome in patients with rectal cancer. Journal of Clinical Oncology. 2001 Jan 1;19(1):157-163.
Tepper, J. E. ; O'Connell, M. J. ; Niedzwiecki, D. ; Hollis, D. ; Compton, C. ; Benson, A. B. ; Cummings, B. ; Gunderson, L. ; Macdonald, J. S. ; Mayer, R. J. / Impact of number of nodes retrieved on outcome in patients with rectal cancer. In: Journal of Clinical Oncology. 2001 ; Vol. 19, No. 1. pp. 157-163.
@article{e47b696e163e466b93999f84ad6f2095,
title = "Impact of number of nodes retrieved on outcome in patients with rectal cancer",
abstract = "Purpose: We postulated that the pathologic evaluation of the lymph nodes of surgical specimens from patients with rectal cancer can have a substantial impact on time to relapse and survival. Patients and Methods: We analyzed data from 1,664 patients with T3, T4, or node-positive rectal cancer treated in a national intergroup trial of adjuvant therapy with chemotherapy and radiation therapy. Associations between the number of lymph nodes found by the pathologist in the surgical specimen and the time to relapse and survival outcomes were investigated. Results: Patients were divided into groups by nodal status and the corresponding quartiles of numbers of nodes examined. The number of nodes examined was significantly associated with time to relapse and survival among patients who were node-negative. For the first through fourth quartiles, the 5-year relapse rates were 0.37, 0.34, 0.26, and 0.19 (P = .003), and the 5-year survival rates were 0.68, 0.73, 0.72, and 0.82 (P = .02). No significant differences were found by quartiles among patients determined to be node-positive. We propose that observed differences are primarily related to the incorrect determination of nodal status in node-negative patients. Approximately 14 nodes need to be studied to define nodal status accurately. Conclusion: These results suggest that the pathologic assessment of lymph nodes in surgical specimens is often inaccurate and that examining greater number of nodes increases the likelihood of proper staging. Some patients who might benefit from adjuvant therapy are misclassified as node-negative due to incomplete sampling of lymph nodes.",
author = "Tepper, {J. E.} and O'Connell, {M. J.} and D. Niedzwiecki and D. Hollis and C. Compton and Benson, {A. B.} and B. Cummings and L. Gunderson and Macdonald, {J. S.} and Mayer, {R. J.}",
year = "2001",
month = "1",
day = "1",
language = "English (US)",
volume = "19",
pages = "157--163",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "1",

}

TY - JOUR

T1 - Impact of number of nodes retrieved on outcome in patients with rectal cancer

AU - Tepper, J. E.

AU - O'Connell, M. J.

AU - Niedzwiecki, D.

AU - Hollis, D.

AU - Compton, C.

AU - Benson, A. B.

AU - Cummings, B.

AU - Gunderson, L.

AU - Macdonald, J. S.

AU - Mayer, R. J.

PY - 2001/1/1

Y1 - 2001/1/1

N2 - Purpose: We postulated that the pathologic evaluation of the lymph nodes of surgical specimens from patients with rectal cancer can have a substantial impact on time to relapse and survival. Patients and Methods: We analyzed data from 1,664 patients with T3, T4, or node-positive rectal cancer treated in a national intergroup trial of adjuvant therapy with chemotherapy and radiation therapy. Associations between the number of lymph nodes found by the pathologist in the surgical specimen and the time to relapse and survival outcomes were investigated. Results: Patients were divided into groups by nodal status and the corresponding quartiles of numbers of nodes examined. The number of nodes examined was significantly associated with time to relapse and survival among patients who were node-negative. For the first through fourth quartiles, the 5-year relapse rates were 0.37, 0.34, 0.26, and 0.19 (P = .003), and the 5-year survival rates were 0.68, 0.73, 0.72, and 0.82 (P = .02). No significant differences were found by quartiles among patients determined to be node-positive. We propose that observed differences are primarily related to the incorrect determination of nodal status in node-negative patients. Approximately 14 nodes need to be studied to define nodal status accurately. Conclusion: These results suggest that the pathologic assessment of lymph nodes in surgical specimens is often inaccurate and that examining greater number of nodes increases the likelihood of proper staging. Some patients who might benefit from adjuvant therapy are misclassified as node-negative due to incomplete sampling of lymph nodes.

AB - Purpose: We postulated that the pathologic evaluation of the lymph nodes of surgical specimens from patients with rectal cancer can have a substantial impact on time to relapse and survival. Patients and Methods: We analyzed data from 1,664 patients with T3, T4, or node-positive rectal cancer treated in a national intergroup trial of adjuvant therapy with chemotherapy and radiation therapy. Associations between the number of lymph nodes found by the pathologist in the surgical specimen and the time to relapse and survival outcomes were investigated. Results: Patients were divided into groups by nodal status and the corresponding quartiles of numbers of nodes examined. The number of nodes examined was significantly associated with time to relapse and survival among patients who were node-negative. For the first through fourth quartiles, the 5-year relapse rates were 0.37, 0.34, 0.26, and 0.19 (P = .003), and the 5-year survival rates were 0.68, 0.73, 0.72, and 0.82 (P = .02). No significant differences were found by quartiles among patients determined to be node-positive. We propose that observed differences are primarily related to the incorrect determination of nodal status in node-negative patients. Approximately 14 nodes need to be studied to define nodal status accurately. Conclusion: These results suggest that the pathologic assessment of lymph nodes in surgical specimens is often inaccurate and that examining greater number of nodes increases the likelihood of proper staging. Some patients who might benefit from adjuvant therapy are misclassified as node-negative due to incomplete sampling of lymph nodes.

UR - http://www.scopus.com/inward/record.url?scp=0035156320&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035156320&partnerID=8YFLogxK

M3 - Article

VL - 19

SP - 157

EP - 163

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 1

ER -